Rat Y' bile acid binders (33 kD) have been previously recognized as cytosolic bile acid binding proteins (Sugiyama, Y., T. Yamada, and N. Kaplowitz, 1983, J. Biol. Chem., 258:3602-3607). We have now determined that these Y' binders are 3a-hydroxysteroid dehydrogenases (3a-HSD), bile acid-metabolizing enzymes. 3a-HSD activity copurified with lithocholic acid-binding activity after sequential gel filtration, chromatofocusing, and affinity chromatography. Three peaks of 3a-HSD activity (I, II, III) were observed in chromatofocusing and all were identified on Western blot by a specific Y' binder antiserum. 3a-HSD-I, the predominant form, was purified and functioned best as a reductase at pH 7.0 with a marked preference for NADPH. Michaelis constant values for mono-and dihydroxy bile acids were 1-2
Introduction
The translocation ofbile acids by the liver from sinusoidal blood to bile is of critical importance in the generation of bile flow. Recent work has begun to elucidate the mechanisms for membrane transport of bile acids at the sinusoidal and canalicular poles of the hepatocytes (1-3). However, the mechanism for intracellular transfer of bile acids from one surface to the other is poorly understood (4, 5) . To better understand the intracellular handling of bile acids, we have identified, purified, and characterized the binding affinities of cytoplasmic proteins in rat liver that interact with bile acids (6, 7) . Two unrelated families of proteins seem to bind bile acids with high affinity, namely ligandins (45-50-kD dimers) (8) and Y' proteins (33-kD monomers) (6) . Ligandins are glutathione S-transferases that bind bile acids at a nonsubstrate, high-affinity site. In this report we have sought evidence for enzymatic activity of the Y' binders. We particularly focused on the possibility that the Y' binders were forms of 3a-hydroxysteroid dehydrogenase because we were of 30 ml/h. 2.8-ml fractions were collected and assayed for protein absorbance, enzymatic activity, lithocholic acid binding and pH.
3'-Phosphoadenosine S'-phosphate (PAP)-agarose affinity chromatography. Pooled fractions ofenzyme activity and bile acid binding after chromatofocusing of the Y' were applied to a I X 10-cm column of PAP-agarose equilibrated with buffer 1. The column was initially eluted with buffer I followed by a linear salt gradient consisting of 150 ml of buffer I and 150 ml of buffer I containing 0.2 M sodium chloride. The column was eluted at 12 mi/h. 3-ml fractions were collected and assayed for protein absorbance, bile acid binding, and enzymatic activity.
Enzymatic activities Glutathione S-transferase. Glutathione S-transferase activity was measured by monitoring the conjugation of 20MM l-chloro-2,4-dinitrobenzene and 0.67 mM GSH, as in prior publication (6, 11). 3a-Hydroxysteroid dehydrogenase. 3a-hydroxysteroid dehydrogenase activity was determined by monitoring the consumption or production of the cofactor NADPH or NADH as the respective rate of decrease or increase in A3Q at 370C. For measurement of reductase activity, assays were performed in 0.05 M sodium phosphate, pH 7.0, and dehydrogenation was determined in 0.05 M glycine-sodium hydroxide, pH 9, according to the method ofOesch (9) . Bile acids were dissolved in absolute ethanol; cofactors were dissolved in water. Enzymatic reaction was initiated by the addition of sample to 1.9 ml of buffer after adding 50 MI of bile acid substrate and 50 Ml of nicotinamide cofactor.
Binding studies
Lithocholic acid binding by equilibrium dialysis. Individual column fractions or pooled protein peaks (0.5 ml) were dialyzed in Spectropor #2 membrane placed in 11 of buffer I with 60 nmol of [14C]lithocholic acid (3 uCi) for 40 h at 4°C. Bound over free ratio was determined as previously described (1 1).
ANS displacement method for bile acid binding. Competitive displacement of the fluorescent probe, ANS was performed as previously described (6, 7) with varying concentrations of lithocholic acid and chenodeoxycholic acid added to purified form I (0.1 M) and ANS (15 MM). Inhibition constant (Ki) values were calculated as previously described (6).
Electrophoresis
Sodium dodecyl sulfate/polyacrylamide gel electrophoresis. SDS-PAGE was performed according to the method of Laemmli using 12.5% gel (12) and then silver stained according to the method of Wayne (13) .
Electroblotting and immuno-overlay. SDS gels were electroblotted on nitrocellulose membrane as previously described (1 1) according to the method of Towbin (14) .
Enzyme kinetics Kinetics ofpurified 3a-hydroxysteroid dehydrogenasefor bile acids and cofactors. Kinetic parameters for cofactors and bile acids were determined by monitoring absorbance change (A3Q) of cofactor at 250. Kinetic parameters were determined in 1.0 ml of 0.05 M sodium phosphate, pH 7 .0. When the reactions were carried out at pH 9.0, maximum velocity (V,,,) was altered but Michaelis constant (K.) was unchanged. Pooled Y' fraction was examined for substrate specificity for 3a-hydroxysteroid dehydrogenase. Since this enzyme catalyzes Tauro-7a,12a-dihydroxy-3-oxo-5j-cholanic acid (0. These results with the pooled Y' fraction suggested that dehydrogenase activity was specific for the hydroxy group in the 3 alpha position and that 3-oxo group was required for reductase activity in the absence of a 4-ene structure. The presence of reductase activity with either 5a or 5,B androsterone suggests that the 4-ene structure prevents the reduction ofthe 3-oxo group by the 3a-HSD. In accordance with the purification protocol used in the initial identification of the Y' bile acid binder (6) , pooled Y' fraction was further fractionated by chromatofocusing. A pH gradient from 6.5 to 4.5 was utilized so as to improve the resolution of this method whereas the initial purification protocol utilized a pH gradient from 7 to 4 (6). Fig. 2 illustrates the elution profile ofthe pooled Y' fraction. Three distinct peaks corresponding to lithocholic acid binding and 3a-hydroxysteroid dehydrogenase activity were observed eluting at pH 5.40, 5.35, and 5.20, using either the substrate 3-oxo-cholic acid or cholic acid (3a,7a, 12a-trihydroxy-5,B-cholanic acid). The elution pattern of enzymatic activity was identical for unconjugated and conjugated mono-, di-, and trihydroxy bile acids (not shown). The pH at which bile acid binders I and II eluted in our previous report (pH 5.6 and 5.5, respectively) are comparable with these results. However, improved resolution now reveals three peaks as opposed to the two previously identified. These three peaks are now designated 3a-hydroxysteroid dehydrogenase-I, II, and III. 3a-Hydroxysteroid dehydrogenase-I (bile acid binder I) is the predominant form, constituting 60-70% of the total 3a-hydroxysteroid dehydrogenase activity in the Y' fraction. Coelution of both bile acid binding and 3a-hydroxysteroid dehydrogenase activity strongly suggested that the Y' bile acid binders are in fact 3a-hydroxysteroid dehydrogenase.
Further purification of lithocholic acid binding and 3a-hydroxysteroid dehydrogenase activity corresponding to the major form (I) was performed with two different approaches. As in our previous report (6) , hydroxyapatite chromatography of pooled 3a-hydroxysteroid dehydrogenase/bile acid binder I from chromatofocusing was performed. Both binding and enzymatic activity coeluted along with the bulk ofthe protein and this fraction Recovery of enzyme activity from gel filtration and chromatofocusing was > 80%. However, recovery from hydroxyapatite was only 20%. Thus, to insure not missing other forms of the enzyme, the pooled form I from chromatofocusing was alternatively purified with affinity chromatography on PAPagarose. This approach has been successively employed by others for purification of dehydrogenases. Fig. 3 depicts the elution of lithocholic acid binding and enzymatic activity as a single peak corresponding to the bulk of protein. Recovery of enzymatic activity was 40%. The protein from the pooled fractions corresponding to this peak was homogeneous on SDS-PAGE (Fig.  4 , lane C') with Mr 33 kD. Thus, only one peak of enzymatic and bile acid-binding activity was identified with either hydroxyapatite or PAP-agarose for purification of 3a-hydroxysteroid dehydrogenase-I from chromatofocusing. The purification (-300-fold) of 3a-hydroxysteroid dehydrogenase-I to homogeneity is summarized in Table III .
Immunochemical identification. Confirmation that the purified 3a-hydroxysteroid dehydrogenase-I is identical to the previously purified Y' bile acid binder was determined by immuno-overlay experiments. The SDS gel of the purified 3a-hydroxysteroid dehydrogenase-I after PAP-agarose affinity chromatography and pooled fractions of 3a-hydroxysteroid dehydrogenase-I, II, and III from chromatofocusing were electroblotted onto nitrocellulose and probed with a previously characterized polyclonal rabbit antiserum specific for Y' bile acid binders (1 1) (Fig. 4) . No binding was identified with preimmune serum (not shown). The purified protein and 3a-hydroxysteroid dehydrogenase-I, II, and III from chromatofocusing were recognized by the antiserum. pH optima and kinetics of3a-hydroxysteroid dehydrogenase-L Fig. 5 illustrates the effects of pH on both reductase and dehydrogenase activity of form I. A broad pH optimum from 5 to 8 for reductase activity with 3-oxo-cholic acid was observed, indicating optimum activity at physiologic pH. The peak dehydrogenase activity with cholic acid was limited to a narrow pH range between 8.5 and 9.5, as has been previously reported with other substrates (9) . Table IV summarizes the Km values for various cofactors. NADP+ and NADPH were the preferred cofactors over NAD' and NADH for the dehydrogenase and reductase activities, respectively. Km for various bile acids are also listed in Table IV . Mono-and dihydroxy bile acids in the unconjugated or con- Dehydrogenase activities at pH 9.0 were greater than pH 7.0 due to an increase in Vmax. pH had no effect on the Km values for bile acids (not shown). Identification ofproducts. The enzymatic activity of bile acid binder as 3a-hydroxysteroid dehydrogenase was also confirmed by examining the bile acid products ofthe reaction. Purified 3a-hydroxysteroid dehydrogenase-I was incubated at pH 7.4 with In addition to incubation of the purified enzyme with bile acid and a single cofactor, a mixture of the four nicotinamide cofactors mimicking the normal redox state in the liver was employed (19, 20) . Radiolabelled cholic and 3-oxo-cholic acids (10 MtM) were separately incubated with this mixture of cofactors and radiolabelled products identified by TLC. Fig. 6 depicts the complete and rapid reduction of3-oxo-cholic to cholic acid under these conditions, whereas minimal conversion of cholic to 3-oxo-cholic acid was observed.
3a-Hydroxysteroid dehydrogenase activity in isolated hepatocytes. Isolated hepatocytes (2 X 106/ml) were incubated with radiolabelled cholic (100 uM) or 3-oxo-cholic acid (10 MM). Fig.   7 illustrates the rapid and complete conversion of 3-oxo-cholic to cholic acid whereas minimal conversion of cholic to 3-oxocholic acid was observed. No 3-oxo-cholic acid was detected in the extracts from hepatocytes indicating rapid reduction after uptake by the cells. Uptake of cholic acid by the cells was confirmed by the finding that nearly all the cholic acid was in a conjugated form by 30 min. No isocholic acid was detected in either the medium or within the hepatocyte. Thus, in the intact hepatocyte, 3a-hydroxysteroid dehydrogenases preferentially function as 3-oxo-bile acid reductases.
Competitive inhibition of reduction of 3-oxo-cholic acid by cholic acid. The effect ofpresence or absence of cholic acid (100 ,MM) on the reduction of 3-oxo-cholic acid (range 3-80 MM) by purified 3a-hydroxysteroid dehydrogenase-I (0.7 MM) with NADPH (3 ,M) was examined. The data are depicted in Fig. 8 in an Eadie-Scatchard plot demonstrating competitive inhibition by cholic acid. The calculated Ki value for cholic acid (137 MM) is comparable with the Km for cholic acid (105 uM), suggesting that cholic acid is capable of binding with the same affinity to 3a-hydroxysteroid dehydrogenase whether it is a substrate or ad inhibitor. Thus, bile acids may still bind and inhibit 3a-hy- droxysteroid dehydrogenase even though the enzyme preferentially functions as 3-oxo-bile acid reductase under normal physiological conditions.
Discussion
Our laboratory previously identifed the Y' bile acid binders in hepatic cytosol. Recently we were struck with the similarities between the proteins we had identified (6) and published characteristics of 3a-hydroxysteroid dehydrogenase (9) . Since the latter can catalyze oxidoreduction of bile acids we were even more suspicious that the binding activity represented the interaction ofbile acids with an active site on an enzyme. Therefore, we identified the elution of 3a-hydroxysteroid dehydrogenase activity in gel filtration. Enzyme activity coeluted with the Y' lithocholic acid binders. We then proceeded to purify both enzyme and binding activity exactly as we had previously described for the binders and in a modification of the procedure. In both cases, copurification was demonstrated. The improved resolution of our current techniques permitted identification of one major and two minor forms of binding activity. Previously we had observed only two forms. To further prove that the Y' binders are 3a-hydroxysteroid dehydrogenases, we demonstrated the re- action of binder-I antisera with an identical molecular weight form of 3a-hydroxysteroid dehydrogenase in peaks I, II, and III from chromatofocusing and the homogeneous 3a-hydroxysteroid dehydrogenase-I. Other investigators also have noted multiple molecular forms of 3a-hydroxysteroid dehydrogenase (21) .
Having proved the identity of the Y' bile acid binders and 3a-hydroxysteroid dehydrogenase, we performed a series of experiments to characterize the types of reaction catalyzed by the pure enzyme and the nature of the enzymatic activity in intact hepatocytes. The purified enzyme could catalyze a bidirectional oxidoreduction. Oxidation (dehydrogenase activity) had a very high, unphysiologic pH optimum whereas reductase activity was most active in the physiologic pH range. Furthermore, the enzyme exhibited a marked preference for pyridine nucleotides, especially NADPH. This preference for NADPH has been noted by other investigators (21, 22) . Since NADPH is the predominant form under normal redox conditions and the reductase activity is optimal at normal intracellular pH, we predicted that the enzyme would function mainly as a reductase in cells. This hypothesis was confirmed in two types of experiments, one using purified enzyme and a mixture of cofactors to mimick physiologic redox conditions and the other using freshly isolated hepatocytes. In both cases, there was a rapid reduction of 3-oxocholic acid to cholic acid but the reverse reaction was negligible. Thus, our data suggests that 3a-hydroxysteroid dehydrogenase is a reductase and not a dehydrogenase under physiologic conditions.
We found that the enzyme had a Km of 1-2 ,M for lithocholic and chenodeoxycholic acids and their taurine conjugates but a much higher Km (-100 ,uM) for cholic acid. In examining the conversion of 3-oxo-cholic acid to cholic acid in the presence ofexcess NADPH, we found that cholic acid could competitively inhibit the reductase activity. The Ki value for inhibition by cholic acid was comparable with the Km value for cholic acid as a substrate for the dehydrogenase activity. This indicates that 3a-hydroxy bile acids can bind to the enzyme's active site without undergoing biotransformation. Therefore, it remains possible that these enzymes serve a dual role: reductases for 3-oxo-bile acids and cytoplasmic bile acid binders. There is another possible important feature of bile acid binding and inhibition of 3-oxobile acid reductase activity. In bile acid synthesis, a common 7a-hydroxy or 7a, 12a-dihydroxy-cholestan4-ene-3-one precursor is believed to undergo reduction by 3a-hydroxysteroid dehydrogenase (23) . Theoretically, this step may be a point of regulation in which high concentrations of bile acids periodically present in hepatocytes inhibit this key step in bile acid synthesis. More work will be required to examine this hypothesis.
The reductase activity of 3a-hydroxysteroid dehydrogenase, aside from being important in bile acid synthesis, may be important in reducing 3-oxo-bile acids returning to the liver after colonic bacterial metabolism (24) or produced by an NAD+-dependent hepatic microsomal 3f3-hydroxy bile acid dehydrogenase (25-27) which acts on 3#-hydroxy bile acids produced by bacteria (28, 29) . Although 3,B-hydroxy bile acids have been identified in portal blood, they are absent in bile (28) . Therefore, a conserted action of two hepatic enzymes may account for this efficient conversion: microsomal NAD+-3#3-hydroxysteroid dehydrogenase and cytosolic 3a-hydroxysteroid dehydrogenase (NADPH 3-oxo reductase). The cofactor preference ofthese two different enzymes is probably responsible for the epimerization at the 3 position. NAD+ predominates over NADH and is the known preferred cofactor for the microsomal enzyme (25 (9, 21, 22) . The enzyme has been implicated in the biosynthetic oxidoreduction of the 3-position of a wide variety of steroid hormone substrates. In addition, 3a-hydroxysteroid dehydrogenase has been shown to catalyze dihydrodiol dehydrogenase activity that may be important in the detoxification of dihydrodiol carcinogens (31, 32) . The enzymatic characteristics of the cytosolic 3a-hydroxysteroid dehydrogenase with regard to bile acid metabolism have not been as intensively studied as with steroid hormones or dihydrodiol substrates. Penning and Talalay (22) and Vogel and Oesch (9) , although working with a purified form of the enzyme, have not examined bile acids as substrates. Studies examining either the reduction or dehydrogenation of bile acids by the cytosolic 3&-hydroxysteroid dehydrogenase have been limited because of the use of crude cytosolic extracts or impure protein preparations. Usui and coworkers partially purified 3a-hydroxysteroid dehydrogenase by ammonium sulfate precipitation of cytosol followed by gel filtration. They identified complete stereospecific reduction oftri-oxo cholic acid (3,7,12-tri-oxo-5#-cholanic acid) to 3a-hydroxy-7, 12-di-oxo-cholic acid with preference for the cofactor, NADPH (26) . Berseus partially purified 3a-hydroxysteroid dehydrogenase and characterized its substrate specificity and kinetics (23) . The Km for cofactor preference and pH optimum were similar to our results. More recently, Ikeda et al. identified multiple forms of 3a-hydroxysteroid dehydrogenase in rat liver and purified two forms (21, 33) . Their purification scheme consisted of sequential ammonium sulfate precipitation, anionic and cationic ion exchange chromatography, chromatofocusing, and red-sepharose affinity chromatography. Since their procedure differs from ours, it is difficult to directly compare the forms of 3a-hydroxysteroid dehydrogenase that we and they have identified. There is close agreement between the results of the two laboratories with respect to molecular weight and pH optima. However, our enzyme kinetic data differ markedly from theirs in showing an order of magnitude higher affinity (lower Km) for mono-and dihydroxy bile acids. In addition our Km values for NADPH and NADP+ are two to three orders of magnitude lower (higher affinity) than theirs. The reason for this discrepancy may be due to differences in stability of their preparation with loss of affinity or strain differences. They studied Wistar and we used Sprague-Dawley rats.
In summary, we have proved that the previously identified Y' bile acid binders are 3a-hydroxysteroid dehydrogenases. On the basis of pH optima and cofactor preferences, we have shown that this enzyme, both in purified form and in cells, functions as a 3-oxo-bile acid reductase. Since the enzyme can bind bile acids at the active site without biotransformation, 3a-hydroxysteroid dehydrogenase activity might be regulated by bile acid flux through the liver, and these enzymes may still serve as cytosolic binders under normal redox conditions. 3a-Hydroxysteroid Dehydrogenase and Y' Binders 433
